Jul 21, 2014
Cerecor Inc. Closes on Initial Tranche of US$32M Series B Financing
Cerecor Inc., a clinical stage biopharmaceutical company developing innovative treatments to make a difference in the lives of patients suffering from nervous system disorders, today announced the closing of the first tranche of a $32M Series B financing.
MPM Technologies/Carbon Cycle Power and Wheeler Industries to Begin...
MPM Technologies, Inc., subsidiary Carbon Cycle Power has completed engineering/design review for its gasification technology and is moving into the construction phase of a demonstration unit with Spokane manufacturer Wheeler Industries, Inc. CCP's waste-to-value solution - a patent-pending photon-induced plasma arc gasification technology - will ... (more)
Med-tech startup True North raises $22M to launch
Biotechnology startup True North Therapeutics nabbed its first round of funding totaling $22 million to move its flagship drug into clinical development.
Wall Street Journal
The Daily Startup: Venture Debt Firms Making Deals, Despite Competition
The number of venture debt financings has been in general decline since 2010, as increasingly attractive growth-stage valuations meant companies didn't need to turn to less-expensive debt financing.